The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNostrum Oil&gas Regulatory News (NOG)

Share Price Information for Nostrum Oil&gas (NOG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.30
Bid: 5.22
Ask: 6.30
Change: 0.34 (6.27%)
Spread: 1.08 (20.69%)
Open: 5.20
High: 5.30
Low: 5.20
Prev. Close: 5.42
NOG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

30 Jun 2023 12:34

RNS Number : 5861E
Nostrum Oil & Gas PLC
30 June 2023
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

London, 30 June 2023

 

Results of Annual General Meeting

 

Following today's Annual General Meeting ("AGM"), convened by the Notice of AGM dated 6 June 2023, Nostrum Oil & Gas PLC ("Nostrum", or the "Company"), an independent oil and gas company engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin, announces the results of the poll for each resolution set out in the Notice of AGM. The results of the poll for each resolution were as follows:

 

NO

RESOLUTION

VOTES FOR

%

VOTES AGAINST

%

VOTES TOTAL

% of ISSUED SHARE CAPITAL VOTED

VOTES WITHHELD

1.

To receive the Company's Annual Report and Accounts for the year ended 31 December 2022.

79,446,736 

97.16

2,323,125

2.84

81,769,861

48.28

1,300

2.

To approve the Directors' Remuneration Report, other than the part containing the Directors' Remuneration Policy, in the form set out in the Company's Annual Report and Accounts for the year ended 31 December 2022.

68,102,538 

83.28

13,668,623 

16.72

81,771,161

48.28

0

3.

To approve a new remuneration policy and to authorise the Remuneration Committee to do all acts and things it may consider necessary or desirable in connection with the same.

65,661,825 

80.30

16,109,336 

19.70

81,771,161

48.28

0

4.

To reappoint Mr Khan as a Director.

79,446,682 

97.16

2,324,479

2.84

81,771,161

48.28

0

5.

To appoint Mr Whyte as a director

68,102,592 

83.28

13,668,569

16.72

81,771,161

48.28

0

6.

To appoint Mr Cox as a director

68,102,592 

83.28

13,668,569

16.72

81,771,161

48.28

0

7.

To appoint Mr Hopkinson as a director

68,102,592 

83.28

13,668,569

16.72

81,771,161

48.28

0

8.

To appoint Ms Paulus as a director

79,446,682 

97.16

2,324,479

2.84

81,771,161

48.28

0

9.

To appoint Mr Gudgeon as a director

68,102,592 

83.28

13,668,569

16.72

81,771,161

48.28

0

10.

To appoint MacIntyre Hudson LLP as Auditor of the Company.

68,102,538 

83.29

13,667,323

16.71

81,769,861

48.28

1,300

11.

To authorise the Directors to determine the Auditor's remuneration on the recommendation of the Audit Committee.

79,446,682 

97.16

2,323,179

2.84

81,769,861

48.28

1,300

12.

To authorise the Directors to allot Ordinary Shares.*

Not applicable

-

Not applicable

-

Not applicable

-

Not applicable

13.

To disapply preemption rights generally.*

Not applicable

-

Not applicable

-

Not applicable

-

Not applicable

14.

To disapply preemption rights in connection with an acquisition or specified capital investment.*

Not applicable

-

Not applicable

-

Not applicable

-

Not applicable

 

* Following the publication of the Notice of AGM on 6 June 2023, certain of the Company's shareholders engaged with the Company and questioned the need for the proposed resolutions given that the Company has no immediate need to issue shares and raise additional capital following the successful completion of the restructuring in February 2023. In light of such shareholder feedback, the Board decided to withdraw Resolutions 12, 13 and 14 from the meeting.

Votes "for" include proxy appointments which give discretion to the Chairman of the AGM.

 

A "Vote Withheld" is not a vote in law and is not counted in the calculation of proportion of votes "For" or "Against" a resolution.

 

For the purposes of section 341 of the UK Companies Act 2006, the votes validly cast are expressed in the table as a percentage of the Company's total issued ordinary share capital (excluding shares held in treasury) as at close of business on Wednesday 28 June 2023 being the time at which a shareholder had to be registered in the Company's register of members in order to attend and vote at the AGM. The number of issued ordinary shares of the Company was 169,381,561 ordinary shares of £0.01 each.

 

In accordance with Listing Rule 9.6.2, copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism, and can be viewed at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

LEI: 2138007VWEP4MM3J8B29

 

Further information

For further information please visit www.nog.co.uk

 

Further enquiries

Nostrum Oil & Gas PLC

Ulugbek Makhmadiyarov

ir@nog.co.uk

 

Instinctif Partners - UK

Tim McCall

Galyna Kulachek

Vivian Lai

+ 44 (0) 207 457 2020

nostrum@instinctif.com

About Nostrum Oil & Gas

Nostrum Oil & Gas PLC is an independent oil and gas company currently engaging in the production, development and exploration of oil and gas in the pre-Caspian Basin. Its shares are listed on the London Stock Exchange (ticker symbol: NOG) and the Astana International Exchange (ticker symbol: NOG). The principal producing asset of Nostrum Oil & Gas PLC is the Chinarevskoye field that is being operated by a wholly-owned subsidiary of Nostrum Oil & Gas PLC - Zhaikmunai LLP, who is the sole holder of the subsoil use rights with respect to the development of the field.

 

Forward-Looking Statements

Some of the statements in this document are forward-looking. Forward-looking statements include statements regarding the intent, belief and current expectations of the Company or its officers with respect to various matters. When used in this document, the words "expects", "believes", "anticipates", "plans", "may", "will", "should" and similar expressions, and the negatives thereof, are intended to identify forward-looking statements. Such statements are not promises nor guarantees and are subject to risks and uncertainties that could cause actual outcomes to differ materially from those suggested by any such statements.

 

No part of this announcement constitutes, or shall be taken to constitute, an invitation or inducement to invest in the Company or any other entity, and shareholders of the Company are cautioned not to place undue reliance on the forward-looking statements. Save as required by the relevant listing rules and applicable law, the Company does not undertake to update or change any forward-looking statements to reflect events occurring after the date of this announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFMMBTMTJJBTJ
Date   Source Headline
29th Apr 20227:00 amRNSNotice of Revised Full Year Results Date
27th Apr 20224:40 pmRNSSecond Price Monitoring Extn
27th Apr 20224:35 pmRNSPrice Monitoring Extension
21st Apr 202211:51 amRNSNotice of Revised Full Year Results Date
13th Apr 20221:46 pmRNSPublication of Circular/Notice of General Meeting
13th Apr 202210:25 amRNSProposed Restructuring & Related Party Transaction
8th Apr 20224:40 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
6th Apr 20223:44 pmRNSRestatement of impairment charge in prior year
22nd Mar 20224:35 pmRNSPrice Monitoring Extension
21st Mar 20224:41 pmRNSSecond Price Monitoring Extn
21st Mar 20224:35 pmRNSPrice Monitoring Extension
18th Mar 20224:41 pmRNSSecond Price Monitoring Extn
18th Mar 20224:36 pmRNSPrice Monitoring Extension
28th Feb 20224:41 pmRNSSecond Price Monitoring Extn
28th Feb 20224:37 pmRNSPrice Monitoring Extension
22nd Feb 20229:15 amRNSDirector Declaration
15th Feb 20224:41 pmRNSSecond Price Monitoring Extn
15th Feb 20224:36 pmRNSPrice Monitoring Extension
9th Feb 20224:41 pmRNSSecond Price Monitoring Extn
9th Feb 20224:35 pmRNSPrice Monitoring Extension
7th Feb 20227:00 amRNSReceipt of Consents in respect of Solicitation
4th Feb 20224:36 pmRNSPrice Monitoring Extension
28th Jan 20227:00 amRNSOperational Update for 4Q and FY2021
24th Jan 20224:42 pmRNSSecond Price Monitoring Extn
24th Jan 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20221:46 pmRNSConsent Solicitation relating to Senior Notes
20th Jan 20224:41 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
19th Jan 20225:36 pmRNSRelated Party Transaction update
19th Jan 20224:41 pmRNSSecond Price Monitoring Extn
19th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 20224:41 pmRNSSecond Price Monitoring Extn
18th Jan 20224:36 pmRNSPrice Monitoring Extension
18th Jan 202212:26 pmRNSUpdate on accessions to lock-up agreement
5th Jan 20224:36 pmRNSPrice Monitoring Extension
23rd Dec 20214:59 pmRNSLock-up agreement and restructuring terms
21st Dec 20217:00 amRNSStatement regarding recent media speculation
17th Dec 20211:00 pmRNSExtension of Forbearance Agreement
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:35 pmRNSPrice Monitoring Extension
6th Dec 202111:45 amRNSExtension of Forbearance Agreement
6th Dec 20218:36 amRNSTR-1: Notification of major holdings
26th Nov 20214:41 pmRNSSecond Price Monitoring Extn
26th Nov 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20219:00 amRNSExtension of Forbearance Agreement
23rd Nov 20219:00 amRNSRE AGM vote on authorisation to allot shares
16th Nov 20217:00 amRNS9M 2021 Financial Results
9th Nov 20219:00 amRNSExtension of Forbearance Agreement
29th Oct 20217:00 amRNSOperational Update for 3Q and 9M 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.